The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $71.90 in the prior trading day, Vaxcyte Inc (NASDAQ: PCVX) closed at $68.56, down -4.65%. In other words, the price has decreased by -$4.65 from its previous closing price. On the day, 1.17 million shares were traded. PCVX stock price reached its highest trading level at $72.66 during the session, while it also had its lowest trading level at $68.39.
Ratios:
Our goal is to gain a better understanding of PCVX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.75 and its Current Ratio is at 12.75. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on December 20, 2024, initiated with a Buy rating and assigned the stock a target price of $135.
On December 07, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $69.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 05 ’25 when Eydelman Mikhail sold 5,000 shares for $70.74 per share. The transaction valued at 353,699 led to the insider holds 41,620 shares of the business.
Eydelman Mikhail bought 5,000 shares of PCVX for $344,350 on Mar 05 ’25. On Mar 03 ’25, another insider, Wassil Jim, who serves as the CHIEF OPERATING OFFICER of the company, sold 8,000 shares for $73.27 each. As a result, the insider received 586,165 and left with 154,931 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PCVX now has a Market Capitalization of 8827922432 and an Enterprise Value of 7151798784.
Stock Price History:
The Beta on a monthly basis for PCVX is 1.02, which has changed by 0.049635053 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, PCVX has reached a high of $121.06, while it has fallen to a 52-week low of $58.10. The 50-Day Moving Average of the stock is -15.03%, while the 200-Day Moving Average is calculated to be -23.18%.
Shares Statistics:
The stock has traded on average 1.13M shares per day over the past 3-months and 979100 shares per day over the last 10 days, according to various share statistics. A total of 128.76M shares are outstanding, with a floating share count of 125.12M. Insiders hold about 2.83% of the company’s shares, while institutions hold 107.91% stake in the company. Shares short for PCVX as of 1741910400 were 12609286 with a Short Ratio of 11.17, compared to 1739491200 on 13334612. Therefore, it implies a Short% of Shares Outstanding of 12609286 and a Short% of Float of 11.07.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Vaxcyte Inc (PCVX) is currently under the scrutiny of 2.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.97, with high estimates of -$0.86 and low estimates of -$1.08.
Analysts are recommending an EPS of between -$3.48 and -$4.88 for the fiscal current year, implying an average EPS of -$4.3. EPS for the following year is -$4.72, with 5.0 analysts recommending between -$4.14 and -$5.42.
